Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

1.0K
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
1.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Actuarial Approach01:20

Actuarial Approach

276
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
276
Life Tables01:22

Life Tables

472
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
472
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

209
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Clinical trial or ″regular clinical practice″? The trasmetir study example].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same author

Genetic Features of Tumours Arising in the Context of Suspected Hereditary Cancer Syndromes with <i>RAD50</i>, <i>RAD51C/D</i>, and <i>BRIP1</i> Germline Mutations, Results of NGS-Reanalysis of BRCA/MMR-Negative Families.

Genes·2025
Same author

[Bioethical issues of Covid-19 in Spain. A systematic review].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2024
Same author

[25 Years from Di Bella affair: what ethical lessons does it leave us?]

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2023
Same author

The Use of Humor in Palliative Care: A Systematic Literature Review.

The American journal of hospice & palliative care·2018
Same journal

[Bioethics after 50 Years: A Reflection on the need to restore human biology to its proper place].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same journal

[The pathologization of the human condition: A critique of the transhumanist rejection of human nature].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same journal

[Ectogenesis. Artificial womb tecnology and clinical practice: Ethical and legal limits].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same journal

Fraud in scientific research and its implications for healthcare professional educators.

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same journal

A qualitative evidence synthesis on the bioethical issues of the use of artificial intelligence in healthcare and proposed solutions.

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
10:08

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans

Published on: May 18, 2022

3.9K

[Ready to die at 75?]

Álvaro Sanz Rubiales1, María Luisa Del Valle Rivero2, Lucía Mateo Otero3

  • 1Hospital Universitario del Río Hortega. Valladolid. asrubiales@hotmail.com.

Cuadernos De Bioetica : Revista Oficial De La Asociacion Espanola De Bioetica Y Etica Medica
|December 24, 2025
PubMed
Summary
This summary is machine-generated.

Professor Emanuel will refuse non-palliative treatments after 75, citing quality of life and family burden. His decision, while stoic, raises bioethical questions about utilitarianism and individualism in end-of-life care.

Area of Science:

  • Bioethics
  • Medical Ethics
  • Gerontology

More Related Videos

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
10:08

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans

Published on: May 18, 2022

3.9K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.3K